CymaBay Therapeutics, Inc.

MORGAN STANLEY

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/13/2024

Shares

956,945

Value ($000)

22,603

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/13/2024	22,603	0.0%	956,945	12/31/2023
2023 Q3	11/15/2023	7,566	0.0%	507,471	9/30/2023
2023 Q2	8/14/2023	9,020	0.0%	823,699	6/30/2023
2023 Q1	5/15/2023	8,654	0.0%	992,381	3/31/2023
2022 Q4	2/14/2023	1,712	0.0%	273,079	12/31/2022
2022 Q3	11/14/2022	763	0.0%	217,702	9/30/2022
2022 Q2	10/27/2022	1,367	0.0%	463,451	6/30/2022
2022 Q1	10/27/2022	388	0.0%	124,519	3/31/2022
2021 Q4	2/14/2022	374	0.0%	110,799	12/31/2021
2021 Q3	11/15/2021	656	0.0%	179,868	9/30/2021
2021 Q2	8/23/2021	2,210	0.0%	507,083	6/30/2021
2021 Q1	5/17/2021	527	0.0%	116,176	3/31/2021
2020 Q4	2/16/2021	435	0.0%	75,692	12/31/2020
2020 Q3	11/13/2020	456	0.0%	63,057	9/30/2020
2020 Q2	8/14/2020	981	0.0%	281,087	6/30/2020
2020 Q1	5/26/2020	232	0.0%	156,514	3/31/2020
2019 Q4	2/14/2020	4,765	0.0%	2,431,460	12/31/2019